Feasibility of proton pencil beam scanning treatment of free-breathing lung cancer patients

被引:17
作者
Jakobi, Annika [1 ,2 ,3 ,4 ,5 ]
Perrin, Rosalind [6 ]
Knopf, Antje [6 ,7 ]
Richter, Christian [1 ,2 ,3 ,4 ,5 ,8 ,9 ]
机构
[1] Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, OncoRay Natl Ctr Radiat Res Oncol, Fac Med, Dresden, Germany
[2] Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, Univ Hosp Carl Gustav Carus, Dresden, Germany
[3] Tech Univ Dresden, Fac Med, Dept Radiat Oncol, Dresden, Germany
[4] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany
[5] Helmholtz Zentrum Dresden Rossendorf, Inst Radiooncol, Dresden, Germany
[6] Paul Scherrer Inst, Ctr Proton Therapy, Villigen, Switzerland
[7] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands
[8] Partner Site Dresden, German Canc Consortium DKTK, Dresden, Germany
[9] German Canc Res Ctr, Heidelberg, Germany
关键词
RESPIRATORY MOTION; TUMOR MOTION; PARTICLE THERAPY; INTERPLAY; SIMULATION; QUANTIFICATION; MITIGATION; TARGETS;
D O I
10.1080/0284186X.2017.1355107
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The interplay effect might degrade the dose of pencil beam scanning proton therapy to a degree that free-breathing treatment might be impossible without further motion mitigation techniques, which complicate and prolong the treatment. We assessed whether treatment of free-breathing patients without motion mitigation is feasible. Material and methods: For 40 lung cancer patients, 4DCT datasets and individual breathing patterns were used to simulate 4D dynamic dose distributions of 3D treatment plans over 33 fractions delivered with an IBA universal nozzle. Evaluation was done by assessing under- and overdosage in the target structure using the parameters V90, V95, V98, D98, D2, V107 and V110. The impact of using beam-specific target volumes and the impact of changes in motion and patient anatomy in control 4DCTs were assessed. Results: Almost half of the patients had tumour motion amplitudes of less than 5mm. Under- and overdosage was significantly smaller for patients with tumour motion below 5mm compared to patients with larger motion (2% vs. 13% average absolute reduction of V95, 2% vs. 8% average increase in V107, p<.01). Simulating a 33-fraction treatment, the dose degradation was reduced but persisted for patients with tumour motion above 5mm (average Delta V95 of <1% vs. 3%, p<.01). Beam-specific target volumes reduced the dose degradation in a fractionated treatment, but were more relevant for large motion. Repeated 4DCT revealed that changes in tumour motion during treatment might result in unexpected large dose degradations. Conclusion: Tumour motion amplitude is an indicator of dose degradation caused by the interplay effect. Fractionation reduces the dose degradation allowing the unmitigated treatment of patients with small tumour motions of less than 5mm. The beam-specific target approach improves the dose coverage. The tumour motion and position needs to be assessed during treatment for all patients, to quickly react to possible changes, which might require treatment adaptation.
引用
收藏
页码:203 / 210
页数:8
相关论文
共 25 条
[1]   Quantification of interplay effects of scanned particle beams and moving targets [J].
Bert, Christoph ;
Groezinger, Sven O. ;
Rietzel, Eike .
PHYSICS IN MEDICINE AND BIOLOGY, 2008, 53 (09) :2253-2265
[2]   Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer:: A prospective clinical study [J].
Bosmans, Geert ;
van Baardwijk, Angela ;
Dekker, Andre ;
Ollers, Michel ;
Boersma, Liesbeth ;
Minken, Andre ;
Lambin, Philippe ;
De Ruysscher, Dirk .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03) :748-753
[3]   Mapping motion from 4D-MRI to 3D-CT for use in 4D dose calculations: A technical feasibility study [J].
Boye, Dirk ;
Lomax, Tony ;
Knopf, Antje .
MEDICAL PHYSICS, 2013, 40 (06)
[4]   Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer [J].
Chang, Joe Y. ;
Jabbour, Salma K. ;
De Ruysscher, Dirk ;
Schild, Steven E. ;
Simone, Charles B., II ;
Rengan, Ramesh ;
Feigenberg, Steven ;
Khan, Atif J. ;
Choi, Noah C. ;
Bradley, Jeffrey D. ;
Zhu, Xiaorong R. ;
Lomax, Antony J. ;
Hoppe, Bradford S. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 95 (01) :505-516
[5]   Clinical Implementation of Intensity Modulated Proton Therapy for Thoracic Malignancies [J].
Chang, Joe Y. ;
Li, Heng ;
Zhu, X. Ronald ;
Liao, Zhongxing ;
Zhao, Lina ;
Liu, Amy ;
Li, Yupeng ;
Sahoo, Narayan ;
Poenisch, Falk ;
Gomez, Daniel R. ;
Wu, Richard ;
Gillin, Michael ;
Zhang, Xiaodong .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 (04) :809-818
[6]   Tumour Movement in Proton Therapy: Solutions and Remaining Questions: A Review [J].
De Ruysscher, Dirk ;
Sterpin, Edmond ;
Haustermans, Karin ;
Depuydt, Tom .
CANCERS, 2015, 7 (03) :1143-1153
[7]   Technical Note: Simulation of 4DCT tumor motion measurement errors [J].
Dou, Tai H. ;
Thomas, David H. ;
O'Connell, Dylan ;
Bradley, Jeffrey D. ;
Lamb, James M. ;
Low, Daniel A. .
MEDICAL PHYSICS, 2015, 42 (10) :6084-6089
[8]   Motion mitigation for lung cancer patients treated with active scanning proton therapy [J].
Grassberger, Clemens ;
Dowdell, Stephen ;
Sharp, Greg ;
Paganetti, Harald .
MEDICAL PHYSICS, 2015, 42 (05) :2462-2469
[9]   Quantification of Proton Dose Calculation Accuracy in the Lung [J].
Grassberger, Clemens ;
Daartz, Juliane ;
Dowdell, Stephen ;
Ruggieri, Thomas ;
Sharp, Greg ;
Paganetti, Harald .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 89 (02) :424-430
[10]   Motion Interplay as a Function of Patient Parameters and Spot Size in Spot Scanning Proton Therapy for Lung Cancer [J].
Grassberger, Clemens ;
Dowdell, Stephen ;
Lomax, Antony ;
Sharp, Greg ;
Shackleford, James ;
Choi, Noah ;
Willers, Henning ;
Paganetti, Harald .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (02) :380-386